PDF herunterladen
CC BY 4.0 · TH Open 2024; 08(01): e114-e120
DOI: 10.1055/a-2259-0911
Review Article

Anticoagulation Stewardship to Bridge the Implementation Gap in Perioperative Anticoagulation Management

Alfonso J. Tafur 
1   Department of Medicine, Vascular Medicine, NorthShore—Edward-Elmhurst Health, Evanston, Illinois, United States
2   Department of Medicine-Cardiovascular Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois, United States
,
Geoffrey D. Barnes 
3   Frankel Cardiovascular Center and Institute for Healthcare Policy and Innovation Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States
,
Vinai C. Bhagirath 
4   Department of Medicine, McMaster University, Hamilton, Ontario, Canada
,
James Douketis 
4   Department of Medicine, McMaster University, Hamilton, Ontario, Canada
› Institutsangaben Funding This work was supported by the Canadian Institutes of Health Research.
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Lack of alignment of care protocols among providers in health care is a driver of increased costs and suboptimal patient outcomes. Perioperative anticoagulation management is a good example of a complex area where protocol creation is a clinical challenge that demands input from multiple experts. Questions regarding the need for anticoagulation interruptions are frequent. Yet, due to layers of complexity involving analysis of anticoagulation indication, surgical risk, and anesthesia-associated bleeding risk as well as institutional practices, there is heterogeneity in how these interruptions are approached. The recent perioperative anticoagulation guidelines from the American College of Chest Physicians summarize extensive evidence for the management of anticoagulant and antiplatelet medications in patients who undergo elective interventions. However, implementation of these guidelines by individual clinicians is highly varied and often does not follow the best available clinical evidence. Against this background, anticoagulation stewardship units, which exist to improve safety and quality monitoring for the anticoagulated patient, are of growing interest. These units provide a bridge for the implementation of value-based, high-quality guidelines for patients who need perioperative anticoagulation interruption. We use a case to pragmatically illustrate the problem and tactics for change management and implementation science that may facilitate the adoption of perioperative anticoagulation guidelines.

Keywords

perioperative - anticoagulation - implementation - six sigma - nudge - guidelines

Disclosures (past 3 years for me)

A.J.T.: Educational Grant: Janssen. Research Support: Biotap, Janssen, Bristol-Myers Squibb, Anthos, Novartis, Idorsia, Stago, Laguna Health, Doasense. Consulting: Recovery Force.


G.D.B. Grant Funding: Boston Scientific; Consulting: Pfizer, Bristol-Myers Squibb, Janssen, Bayer, AstraZeneca, Sanofi, Anthos, Abbott Vascular, Boston Scientific; DSMB: Translational Sciences (Clinical Events Adjudication Committee); Board of Directors: Anticoagulation Forum


V.C.B.: Honoraria:Bayer


J.D.: Consulting or Education Honoraria: Pfizer, Servier, Leo Pharma, Fresinius Kabi, CytSorb; Non-Employee Contributions with Royalties: Up-to-Date, Merck Manual




Publikationsverlauf

Eingereicht: 13. August 2023

Angenommen: 18. Dezember 2023

Accepted Manuscript online:
01. Februar 2024

Artikel online veröffentlicht:
11. März 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Tafur AJ, Clark NP, Spyropoulos AC. et al. Predictors of bleeding in the perioperative anticoagulant use for surgery evaluation study. J Am Heart Assoc 2020; 9 (19) e017316
    CrossrefPubMedGoogle Scholar
  • 2 Clark NP, Douketis JD, Hasselblad V, Schulman S, Kindzelski AL, Ortel TL. BRIDGE Investigators. Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: analysis of the BRIDGE trial. Am Heart J 2018; 195: 108-114
    CrossrefPubMedGoogle Scholar
  • 3 Clark NP, Witt DM, Davies LE. et al. Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures. JAMA Intern Med 2015; 175 (07) 1163-1168
    CrossrefPubMedGoogle Scholar
  • 4 Douketis JD, Spyropoulos AC, Kaatz S. et al; BRIDGE Investigators. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 2015; 373 (09) 823-833
    CrossrefPubMedGoogle Scholar
  • 5 Spyropoulos AC, Brohi K, Caprini J. et al; SSC Subcommittee on Perioperative and Critical Care Thrombosis and Haemostasis of the International Society on Thrombosis and Haemostasis. Scientific and Standardization Committee Communication: guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk. J Thromb Haemost 2019; 17 (11) 1966-1972
    CrossrefPubMedGoogle Scholar
  • 6 Steinberg BA, Peterson ED, Kim S. et al; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Investigators and Patients. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circulation 2015; 131 (05) 488-494
    CrossrefPubMedGoogle Scholar
  • 7 Tafur AJ, Wysokinski WE, McBane RD. et al. Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients. Ann Oncol 2012; 23 (08) 1998-2005
    CrossrefPubMedGoogle Scholar
  • 8 Tafur AJ, McBane II R, Wysokinski WE. et al. Predictors of major bleeding in peri-procedural anticoagulation management. J Thromb Haemost 2012; 10 (02) 261-267
    CrossrefPubMedGoogle Scholar
  • 9 MacDougall K, Douketis JD, Li N. et al. Effect of direct oral anticoagulant, patient, and surgery characteristics on clinical outcomes in the perioperative anticoagulation use for surgery evaluation study. TH Open 2020; 4 (03) e255-e262
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 10 Douketis JD, Spyropoulos AC, Duncan J. et al. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med 2019; 179 (11) 1469-1478
    CrossrefPubMedGoogle Scholar
  • 11 Douketis JD, Spyropoulos AC, Murad MH. et al. Perioperative management of antithrombotic therapy: an american college of chest physicians clinical practice guideline. Chest 2022; 162 (05) e207-e243
    CrossrefPubMedGoogle Scholar
  • 12 Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med 2011; 104 (12) 510-520
    CrossrefPubMedGoogle Scholar
  • 13 Heidbuchel H, Dagres N, Antz M. et al. Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment. Europace 2018; 20 (12) 1919-1928
    CrossrefPubMedGoogle Scholar
  • 14 Saeed H, Ovalle OG, Bokhary U. et al. National physician survey for nonvalvular atrial fibrillation (NVAF) anticoagulation comparing knowledge, attitudes and practice of cardiologist to PCPs. Clin Appl Thromb Hemost 2020; 26: 1076029620952550
    CrossrefPubMedGoogle Scholar
  • 15 Munk L, van Essen T, van der Hoeven C, Nolte PA, Becker ML. Compliance to perioperative anticoagulation protocols in elderly patients undergoing elective orthopedic procedures: a retrospective observational cohort study on 548 patients. Patient Saf Surg 2023; 17 (01) 9
    CrossrefPubMedGoogle Scholar
  • 16 Burnett AE, Barnes GD. A call to action for anticoagulation stewardship. Res Pract Thromb Haemost 2022; 6 (05) e12757
    CrossrefPubMedGoogle Scholar
  • 17 Kahneman D. Thinking, Fast and Slow. Farrar, Straus and Giroux; 2011
    Google Scholar
  • 18 Djulbegovic B. A framework to bridge the gaps between evidence-based medicine, health outcomes, and improvement and implementation science. J Oncol Pract 2014; 10 (03) 200-202
    CrossrefPubMedGoogle Scholar
  • 19 Flemons K, Bosch M, Coakeley S, Muzammal B, Kachra R, Ruzycki SM. Barriers and facilitators of following perioperative internal medicine recommendations by surgical teams: a sequential, explanatory mixed-methods study. Perioper Med (Lond) 2022; 11 (01) 2
    CrossrefPubMedGoogle Scholar
  • 20 Douketis JD, Syed S, Li N. et al. A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant. Res Pract Thromb Haemost 2020; 5 (01) 159-167
    CrossrefPubMedGoogle Scholar
  • 21 Douketis JD, Syed S, Schulman S. Periprocedural management of direct oral anticoagulants: comment on the 2015 American Society of Regional Anesthesia and Pain Medicine Guidelines. Reg Anesth Pain Med 2016; 41 (02) 127
    CrossrefPubMedGoogle Scholar
  • 22 Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med 2018; 43 (03) 263-309
    CrossrefPubMedGoogle Scholar
  • 23 McCaughan B on behalf of Clinical Excellence Committee. Guidelines on Perioperative Management of Anticoagulant and Antiplatelet Agents Accessed 2022; 12: 30 . Available at:
    PubMed
  • 24 Doherty JU, Gluckman TJ, Hucker WJ. et al. 2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol 2017; 69 (07) 871-898
    CrossrefPubMedGoogle Scholar
  • 25 Violette PD, Lavallée LT, Kassouf W, Gross PL, Shayegan B. Canadian urological association guideline: perioperative thromboprophylaxis and management of anticoagulation. Can Urol Assoc J 2019; 13 (04) 105-114
    PubMedGoogle Scholar
  • 26 Rezaei Bookani K, Minga I, Chander M, Hankewych K, Plassmeier M, Tafur A. Drive-through model for anticoagulation clinics during the COVID-19 pandemic. Clin Appl Thromb Hemost 2020; 26: 1076029620947476
    CrossrefPubMedGoogle Scholar
  • 27 Tafur A, Douketis JD. Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials. Pol Arch Med Wewn 2015; 125 (09) 666-671
    PubMedGoogle Scholar
  • 28 Djulbegovic B, Paul A. From efficacy to effectiveness in the face of uncertainty: indication creep and prevention creep. JAMA 2011; 305 (19) 2005-2006
    CrossrefPubMedGoogle Scholar
  • 29 Wysokinska EM, Wysokinski WE, Ketha S. et al. Periprocedural anticoagulation management of patients with thrombophilia. Am J Med 2016; 129 (09) 986-992
    CrossrefPubMedGoogle Scholar
  • 30 Morita PP, Abhari S, Kaur J, Lotto M, Miranda PADSES, Oetomo A. Applying ChatGPT in public health: a SWOT and PESTLE analysis. Front Public Health 2023; 11: 1225861
    CrossrefPubMedGoogle Scholar
  • 31 Harrison R, Fischer S, Walpola RL. et al. Where do models for change management, improvement and implementation meet? A systematic review of the applications of change management models in healthcare. J Healthc Leadersh 2021; 13: 85-108
    CrossrefPubMedGoogle Scholar
  • 32 Karimi E, Sohrabi Z, Aalaa M. Change management in medical contexts, especially in medical education: a systematized review. J Adv Med Educ Prof 2022; 10 (04) 219-227
    PubMedGoogle Scholar
  • 33 Schaefer JK, Errickson J, Gu X. et al. Assessment of an intervention to reduce aspirin prescribing for patients receiving warfarin for anticoagulation. JAMA Netw Open 2022; 5 (09) e2231973
    CrossrefPubMedGoogle Scholar
  • 34 Thaler R, Sunstein C. Nudge: Improving Decisions about Health, Wealth, and Happiness. Yale University Press; 2008
    Google Scholar
  • 35 Patel MS, Volpp KG, Asch DA. Nudge units to improve the delivery of health care. N Engl J Med 2018; 378 (03) 214-216
    CrossrefPubMedGoogle Scholar
  • 36 Waddell KJ, Shah PD, Adusumalli S, Patel MS. Using behavioral economics and technology to improve outcomes in cardio-oncology. JACC Cardiooncol 2020; 2 (01) 84-96
    CrossrefPubMedGoogle Scholar
  • 37 Golemi I, Salazar Adum JP, Tafur A, Caprini J. Venous thromboembolism prophylaxis using the Caprini score. Dis Mon 2019; 65 (08) 249-298
    CrossrefPubMedGoogle Scholar
  • 38 Optimizing outcomes in venous thromboembolism among hospitalized medically ill patients through an integrated risk assessment program. Am J Manag Care 2022; 2022: 1-17
    PubMedGoogle Scholar
  • 39 Dorsch MP, Chen CS, Allen AL. et al. Nationwide implementation of a population management dashboard for monitoring direct oral anticoagulants: insights from the veterans affairs health system. Circ Cardiovasc Qual Outcomes 2023; 16 (02) e009256
    PubMedGoogle Scholar
  • 40 Han H, Chung G, Sippola E. et al. Improving preprocedure antithrombotic management: Implementation and sustainment of a best practice alert and pharmacist referral process. Res Pract Thromb Haemost 2021; 5 (05) e12558
    CrossrefPubMedGoogle Scholar
  • 41 Barnes GD, Spranger E, Sippola E. et al. Assessment of a best practice alert and referral process for preprocedure antithrombotic medication management for patients undergoing gastrointestinal endoscopic procedures. JAMA Netw Open 2020; 3 (02) e1920548
    CrossrefPubMedGoogle Scholar
  • 42 Cesarelli G, Petrelli R, Ricciardi C. et al. Reducing the healthcare-associated infections in a rehabilitation hospital under the guidance of lean six sigma and DMAIC. Healthcare (Basel) 2021; 9 (12) 1667
    CrossrefPubMedGoogle Scholar
  • 43 Bauchner H, Fontanarosa PB. Health care spending in the United States compared with 10 other high-income countries: what Uwe Reinhardt might have said. JAMA 2018; 319 (10) 990-992
    CrossrefPubMedGoogle Scholar
  • 44 Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA 2018; 319 (10) 1024-1039
    CrossrefPubMedGoogle Scholar
  • 45 Lee VS, Kawamoto K, Hess R. et al. Implementation of a value-driven outcomes program to identify high variability in clinical costs and outcomes and association with reduced cost and improved quality. JAMA 2016; 316 (10) 1061-1072
    CrossrefPubMedGoogle Scholar
  • 46 Rognoni C, Furnari A, Lugli M, Maleti O, Greco A, Tarricone R. Time-driven activity-based costing for capturing the complexity of healthcare processes: the case of deep vein thrombosis and leg ulcers. Int J Environ Res Public Health 2023; 20 (10) 5817
    CrossrefPubMedGoogle Scholar
  • 47 Callese TE, Moriarty JM, Maehara C. et al. Cost drivers in endovascular pulmonary embolism interventions. Clin Radiol 2023; 78 (02) e143-e149
    CrossrefPubMedGoogle Scholar
  • 48 Porter ME. What is value in health care?. N Engl J Med 2010; 363 (26) 2477-2481
    CrossrefPubMedGoogle Scholar